mccx20190331

0001437749-19-010040.txt : 20190515 0001437749-19-010040.hdr.sgml : 20190515 20190515153123 ACCESSION NUMBER: 0001437749-19-010040 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: McorpCX, Inc. CENTRAL INDEX KEY: 0001535079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 260030631 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54918 FILM NUMBER: 19827615 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: (415) 526-2655 MAIL ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Touchpoint Metrics, Inc. DATE OF NAME CHANGE: 20111116 10-Q 1 mccx20190331_10q.htm FORM 10-Q mccx20190331_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑	QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2019

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-54918

MCORPCX, INC.

(Exact name of registrant as specified in its charter)

California

(State or other jurisdiction of incorporation or organization)

26-0030631

(I.R.S. Employer Identification No.)

201 Spear Street, Suite 1100

San Francisco, CA 94105

(Address of principal executive offices, including zip code)

(415) 526-2655

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☑ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☑ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☐

Accelerated Filer

☐

Non-accelerated Filer

☑

Smaller Reporting Company

Emerging growth company

☑

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☑

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Indicated the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 20,426,158 as of May 13, 2019.

MCORPCX, Inc.

Form 10-Q Quarterly Report

TABLE OF CONTENTS

		Page No.

	Part I. - Financial Information	3

Item 1.	Financial Statements.	3

	Consolidated Balance Sheets as of March 31, 2019 (unaudited) and December 31, 2018.	3

	Consolidated Statements of Operations for the Three Months ended March 31, 2019 and 2018 (unaudited).	4

	Consolidated Statements of Shareholders’ Equity for the Three Months ended March 31, 2019 and 2018 (unaudited).	5

	Consolidated Statements of Cash Flows for the Three Months ended March 31, 2019 and 2018 (unaudited).	6

	Notes to Consolidated Financial Statements (unaudited).	7

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	11

Item 3.	Quantitative and Qualitative Disclosure about Market Risk.	17

Item 4.	Controls and Procedures.	17

	Part II. - Other Information	18

Item 1.	Legal Proceedings.	18

Item 1A.	Risk Factors.	18

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	18

Item 3.	Defaults Upon Senior Securities.	18

Item 4.	Mine Safety Disclosures.	18

Item 5.	Other Information.	18

Item 6.	Exhibits.	19

Signatures		20

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS.

McorpCX, Inc.

Consolidated Balance Sheets

	March 31,			December 31,
	2019			2018
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	1,582,935		$	1,350,014
Accounts receivable		382,372			343,036
Total current assets		1,965,307			1,693,050
Long term assets:
Property and equipment, net		89,443			90,074
Capitalized software development costs, net		66,283			108,968
Other assets, net		90,935			72,876
Total assets	$	2,211,968		$	1,964,968

Liabilities and Shareholders' Equity
Liabilities:
Accounts payable and accrued liabilities	$	321,580		$	220,576
Deferred revenue		218,814			122,238
Lease payable		28,939			-
Other current liabilities		1,682			1,536
Total current liabilities		571,015			344,350
Total liabilities		571,015			344,350
Shareholders' equity:
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2019 and December 31, 2018		-			-
Additional paid-in capital		6,470,349			6,454,791
Accumulated deficit		(4,829,396	)		(4,834,173	)
Total shareholders' equity		1,640,953			1,620,618
Total liabilities and shareholders' equity	$	2,211,968		$	1,964,968

The accompanying notes are an integral part of these unaudited consolidated financial statements.

McorpCX, Inc.

Consolidated Statements of Operations

(unaudited)

	Three Months Ended
	March 31,
	2019			2018

Revenue, net
Consulting services	$	965,913		$	556,236
Products and other		44,415			57,618
Total revenue, net		1,010,328			613,854
Cost of goods sold
Labor		258,152			201,439
Products and other		130,248			95,976
Total cost of goods sold		388,400			297,415
Gross profit		621,928			316,439
Expenses
Salaries and wages		293,710			218,959
Contract services		42,180			74,065
Other general and administrative		275,530			222,218
Total expenses		611,420			515,242

Net operating income (loss)		10,508			(198,803	)

Interest expense		(1,231	)		(110	)

Other expense		(4,500	)		(3,803	)

Income (loss) before income taxes		4,777			(202,716	)

Income tax provision		-			-

Net income (loss)	$	4,777		$	(202,716	)

Net income (loss) per share-basic and diluted	$	0.00		$	(0.01	)

Weighted average common shares outstanding-basic and diluted		20,426,158			20,426,158

The accompanying notes are an integral part of these unaudited consolidated financial statements.

McorpCX, Inc.

Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

	Three Months Ended March 31, 2018
							Retained
					Additional		Earnings
	Common Stock				Paid in		(Accumulated
	Shares		Amount		Capital		Deficit)			Total
Balance at December 31. 2017		20,426,158	$	-	$	6,428,997	$	(4,422,957	)	$	2,006,040
Stock based compensation - stock options		-		-		3,087		-			3,087
Net loss		-		-		-		(202,716	)		(202,716	)
Balance at March 31, 2018		20,426,158	$	-	$	6,432,084	$	(4,625,673	)	$	1,806,411

	Three Months Ended March 31, 2019
							Retained
					Additional		Earnings
	Common Stock				Paid in		(Accumulated
	Shares		Amount		Capital		Deficit)			Total
Balance at December 31. 2018		20,426,158	$	-	$	6,454,791	$	(4,834,173	)	$	1,620,618
Stock based compensation - stock options		-		-		15,558		-			15,558
Net income		-		-		-		4,777			4,777
Balance at March 31, 2019		20,426,158	$	-	$	6,470,349	$	(4,829,396	)	$	1,640,953

The accompanying notes are an integral part of these unaudited consolidated financial statements.

McorpCX, Inc.

Consolidated Statements of Cash Flows

(unaudited)

	Three Months Ended March 31,
	2019			2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	4,777		$	(202,716	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:
Depreciation and amortization		50,148			52,705
Stock compensation expense		15,558			3,087
Changes in operating assets and liabilities:
Accounts receivable		(39,336	)		14,989
Other assets		9,273			(18,997	)
Accounts payable and accrued liabilities		101,004			92,635
Lease liability		(5,225	)		-
Other current liabilities		146			-
Deferred revenue		96,576			(59,560	)

Net cash provided by (used in) operating activities		232,921			(117,857	)

FINANCING ACTIVITIES
Repayment of notes payable		-			(8,169	)

Net cash used in financing activities		-			(8,169	)

Increase (decrease) in cash and cash equivalents		232,921			(126,026	)

Cash and cash equivalents, beginning of period		1,350,014			1,616,076

Cash and cash equivalents, end of period	$	1,582,935		$	1,490,050

Supplemental disclosure of cash flow information:
Interest paid	$	1,231		$	110
ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02	$	34,164		$	-

The accompanying notes are an integral part of these unaudited consolidated financial statements.

MCORPCX, INC.

NOTES TO FINANCIAL STATEMENTS

March 31, 2019

(unaudited)

Note 1: Organization and Basis of Presentation

McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on December 14, 2001. We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.

The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on December 14, 2017. On August 16, 2018, the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.

We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization.

The consolidated financial statements and related disclosures as of and for the three months ended March 31, 2019 and 2018, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2018 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2018, filed on Form 10-K with the SEC on April 1, 2019. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the full year.

Note 2: Recent Accounting Pronouncements

In February 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU 2016-02 to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU 2016-02 and these additional ASUs are now codified as Accounting Standards Codification Standard 842 - “Leases” (“ASC 842”). ASC 842 supersedes the lease accounting guidance in Accounting Standards Codification 840 “Leases” (“ASC 840”) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC 842 are not adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on January 1, 2019, the impact of the adoption of ASC 842 resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately $34 thousand. As the right of use asset and the lease payable obligation were the same upon adoption of ASC 842, there was no cumulative effect impact on the Company’s retained earnings.

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC 220, Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018-02 effective January 1, 2019. The adoption of this standard did not have a material impact on the consolidated financial statements.

Note 3. Revenues

Consulting Service Revenues

The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the customer experience being analyzed. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has no alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.

Product and other revenue

Product and other revenue during 2018 and 2019 has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are not subject to the licensing guidance in Topic 606 because the customer can’t take possession of the software at any time and the customer would not be able to operate the software on its own or with another third party. Fees charged to customers of Touchpoint Mapping may include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does not affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do not unbundle such services into separate performance obligations as their pattern of transfer does not differ.

Deferred Revenues (Contract Liabilities)

The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.

The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is $218,814 as of March 31, 2019 and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of $218,814 in 2019 related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is not expected to be recognized beyond fiscal year 2019.

During the three months ended March 31, 2019, we recognized revenue of $75,105, related to our contract liabilities included in deferred revenue at December 31, 2018. During the three months ended March 31, 2018 we recognized revenue of $73,766, related to our contract liabilities included in deferred revenue at December 31, 2017.

Practical Expedients and Exemptions

Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

Note 4: Capitalized Software Development Costs

Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. There were no capitalizable costs during the three months ended March 31, 2019 and 2018.

Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the three-year expected useful life of the software. Capitalized software development costs, net of amortization, were $66,283 and $108,968 as of March 31, 2019 and December 31, 2018, respectively. Amortization expense incurred during the three months ended March 31, 2019 and 2018 was $42,685 and $48,458, respectively, and is included in cost of goods sold in the consolidated statements of operations.

Note 5: Stock-Based Compensation

Our stock-based compensation plan was originally established in 2008. The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could not exceed 30% of any outstanding issue or 2,500,000 shares, whichever was the lower amount.

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016.

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

At March 31, 2019, 1,350,000 stock options were exercisable and $15,558 of total compensation cost related to share-based compensation grants had been recognized for the three months ended March 31, 2019. Unrecognized compensation expense from stock options was $150,041 at March 31, 2019, which is expected to be recognized over a weighted-average vesting period of 2.38 years beginning April 1, 2019.

The following table summarizes our stock option activity for the three months ended March 31, 2019:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2018		2,040,000	$	0.47		6.63		-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2019		2,040,000	$	0.47		6.37		-

Exercisable at March 31, 2019		1,350,000	$	0.60		4.83	$	-

Note 6: Concentrations

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune 500 companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the three months ended March 31, 2019 and 2018, the percentage of sales and the concentrations are:

	2019			2018
Largest client		35	%		32	%
Second largest client		16	%		26	%
Third largest client		15	%		10	%
Next three largest clients		26	%		25	%
All other clients		8	%		7	%
		100	%		100	%

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is no provision made to include an allowance for doubtful accounts.

Note 7: Going Concern

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

We have had material operating losses and have not yet created positive cash flows for a full year. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to increase our net operating income. We believe that our increased revenues in the year ended December 31, 2018 and three months ended March 31, 2019 compared to our financial results for the year ended December 31 2017 and the first quarter of 2018, coupled with our cash balance of $1,582,935 at March 31, 2019, and our belief that sufficient funding may be available from private placements of equity securities or additional borrowings if needed; will enable us to meet our liquidity needs over the next 12 months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing debt, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

Note 8: Basic and Diluted Net Income / (Loss) per Share

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the three months ended March 31, 2019 and 2018, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income / (loss) per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of 1,350,000 for the three months ended March 31, 2019 and 2018.

	Three Months ended
	March 31,
	2019		2018
Net income (loss)	$	4,777	$	(202,716	)
Basic and diluted weighted average common shares outstanding		20,426,158		20,426,158

Net income (loss) per share, basic and diluted	$	0.00	$	(0.01	)

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Cautionary Statement

This Management’s Discussion and Analysis includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: “believe,” “expect,” “plan”, “estimate,” “anticipate,” “intend,” “project,” “will,” “predicts,” “seeks,” “may,” “would,” “could,” “potential,” “continue,” “ongoing,” “should” and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this Form 10-Q. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc. and our subsidiaries.

Critical Accounting Policies and Estimates

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates. We believe that the assumptions and estimates associated with revenue recognition, income taxes, stock-based compensation, research and development costs and impairment of long-lived assets have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

A description of the Company’s critical accounting policies and related judgments and estimates that affect the preparation of the Company’s financial statements is set forth in under the heading “Critical Accounting Policies and Estimates” in Item 7, Management’s Discussion and Analysis of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. With the exception of the policy adoptions discussed in Note 2, such policies were unchanged during the three months ended March 31, 2019.

Overview

We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. We believe that delivering better customer experiences is a powerful, sustainable way for any organization to differentiate themselves from their competition. As such, we are engaged in the business of providing customer experience focused consulting services and where applicable, delivering technology-enabled services that are designed to help corporations improve their customer listening and customer experience management capabilities with the goal of helping them design and deliver better experiences for their customers.

Our primary source of revenue is derived from our consulting services which are intended to help primarily large and medium sized organizations plan, design and deliver better customer experiences in order to maximize their return on investment, improve efficiency, and increase the adoption of our products and services. Our services offered include a range of customer experience management consulting services in the areas of research, strategy development, planning, education, training and best practices, as well as providing customer-centric strategies and implementation roadmaps in support of these strategies.

We have developed on-demand “cloud based” customer experience management software such as Touchpoint Mapping® On-Demand (also marketed as McorpCX | Insights), referred to as “Touchpoint Mapping”, and McorpCX | Persona.

Touchpoint Mapping is a research-based online Software-as-a-Service (“SaaS”) solution designed to provide insights to organizations that can help them improve customer and employee experience, brand, and loyalty. It is designed to be a solution for customer-centric organizations to measure and gather customer data across all their touchpoints, channels and interactions with their customers.

McorpCX | Persona, another online SaaS solution, is designed for developing and managing customer persona, as well as automating the currently manual process of developing, managing and sharing persona across corporations. It is designed to help customer-centric businesses and the agencies and consultancies that serve them to better understand, connect with and serve their customers.

There are many potential unforeseen and significant market and competitive risks associated our current products and services. Though we released the first version of Touchpoint Mapping in 2013, and we released the first version of McorpCX | Persona in 2016, neither product has generated significant sales revenue to date, and we cannot predict the timing or probability of generating material sales revenue from either of them. Additionally, as of the date of this report, we have yet to engage the necessary development and client support or sales staff required to identify, develop, and close material product sales opportunities which we believe is required to achieve our product sales and revenue growth objectives, and we believe that our current software capabilities are more limited in scope than our desired final software platform and as such, we will require significant further software development expenditures, which at this time the Company is not prepared to make. Consequently, in 2018 we suspended actively selling Touchpoint Mapping and McorpCX | Persona until we more fully assess the roadmap to make these products more marketable to clients. As a result, revenues from our consulting services provided to our clients represented a majority of our revenue in 2018 and the three months ended March 31, 2019, and management believes that consulting services will remain our most significant revenue source for the foreseeable future.

Although management still believes that offering technology enabled consulting services can provide long-term profitability and we intend to continue to explore ways to successfully commercialize our software products, in both the short-term and mid-tem, we are focused on expanding our consulting business which we believe may lead to greater revenues for the Company and which could be utilized for cross sale of technology products to our consulting clients. We intend to continue to evaluate our software products to determine the next phase of new product development and potential enhancements to our existing product suite or to identify other software products that may be more conducive to supporting our CX consulting expertise.

The Company is in the process of determining the optimal path forward for our software products based on current market dynamics, the competitive environment and customer feedback. We continue to evaluate various potential strategies with the goal of improving our ability to achieve additional revenue and profit growth for both our software products as well as our consultant services. These possible strategies, which are generally focused on ways to create a more complete slate of customer experience solutions for our clients, include further software or technology development expenditures, pursuit of merger, acquisitions or joint ventures with companies that provide complimentary products and services, software licensing arrangements, and investment in additional infrastructure within our Company. Each of these possible strategies will be thoroughly vetted by our board of directors to assess the expected level of enterprise value creation for each strategy compared to the various risks associated with each possible scenario. In addition, we may require financing to pursue these strategies that is beyond our current financial resources. Accordingly, there is no assurance that we will be able to pursue any strategies that are identified by our board of directors.

We cannot assure you that we will be able to compete successfully against current or potential competitors, or that competition will not have a material adverse effect on our business, financial condition and operations.

Summary of Financial Results

Select financial highlights for the three months ended March 31, 2019:

	●	Total revenue increased by 65% from $613,854 during the first quarter of 2018 to $1,010,328 during the first quarter of 2019.

	●	We recorded net income of $4,777 in the first quarter of 2019, compared to net losses of $202,716 for the first quarter of 2018.

	●	The Company reported EBITDA⁽¹⁾ of $56,157 in the first quarter 2019, compared to $(149,901) in the first quarter of 2018.

	●	The Company had a cash balance of $1,582,935 at March 31, 2019 compared to a cash balance of $1,350,014 at December 31, 2018.

⁽¹⁾ We define EBITDA as net income (loss) plus interest, tax, depreciation and amortization expenses. We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not actual cash costs, and interest and tax expenses are not related to our direct operating activities. See below for a reconciliation of net income (loss) to EBITDA.

Sources of Revenue

Our revenue consists primarily of professional and consulting services, as well as software-enabled product sales and other revenues. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. Product revenue is from productized and software-enabled service sales not elsewhere classified, while other revenue includes reimbursement of related travel costs and out-of-pocket expense.

The consulting services are contracted under master terms and conditions with statements of work (“SOW”) defined for each project. A typical consulting SOW will span a period of 60-180 days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project. In addition, we typically incur travel other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.

We anticipate that fees for professional and consulting services will remain our most significant revenue source in the foreseeable future. We have not obtained material stand-alone sales commitments for Touchpoint Mapping® On-Demand or McorpCX | Persona, and do not anticipate being able to do so until we engage the necessary development, product support to sales and marketing staff to further develop the software and execute product sales opportunities. During the second half of 2017, we stopped further development of our software in order to re-assess the product roadmap to better define the future direction of our software platform.

Subscription agreements for our software solutions have been offered as monthly term agreements which contain a minimum commitment period of at least 12 months, and which have included related setup, upgrades, hosting and support. Professional services have included consulting fees related to implementation, customization, configuration, training and other services.

When we were actively selling the products, we found that the implementation stage of on-demand software and software-enabled services engagements had an average time it took our clients from placing an order to live deployment of our products was between 30 and 45 days. We typically invoiced clients upon inception of subscription agreements for setup and total subscription fees contracted over the term of the agreements, with payment due within 30 days. We then recognized the subscription fee revenue straight-line over the life of the agreement with any associated professional services or separate set-up fee revenue recognized on a percent of project completion basis.

Professional services related to the subscription agreements are invoiced at the inception of the professional services agreement at a negotiated percentage of total fees, often but not exclusively one-third or one-half of the total estimated professional services fees, with the balance of payments due over the duration of the contract as project milestones are met. Amounts invoiced are recorded in accounts receivable and deferred revenue or revenue, depending on whether revenue recognition criteria have been met.

Cost of Goods Sold and General and Administrative Expenses

Cost of Goods Sold

Cost of goods sold has historically consisted primarily of expenses directly related to providing professional and consulting services. Those expenses include contract labor, third-party services, and materials and travel expenses related to providing professional services to our clients. Costs of goods also includes, but is not limited to, product-related hosting and monitoring costs, the cost of licenses for products embedded in the application, amortization of capitalized software development costs, service support costs, and costs related to account and subscription management, as applicable.

Should our client base grow, we intend to continue to invest additional resources in our hosting, technical support and professional services capabilities, as well as our utilization of third-party licensed software.

General and Administrative Expenses

General and administrative expenses consist primarily of salary and related expenses for management, client delivery, finance and accounting, and sales and marketing. These expenses also include contract services, as well as marketing and promotion costs, professional fees, software license fee expenses, administrative costs, insurance, rent and a portion of travel expenses and other overhead, which are categorized as “other general and administrative expenses” in our consolidated financial statements. In addition, the other general and administrative expenses include the professional fees, filing, and registration costs necessary to meet the requirements associated with having to file reports with the United States Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as well as having our stock listed on the TSX Venture Exchange in Canada and quoted on the OTCQB venture marketplace in the United States.

Sales and marketing expenses are currently reflected in salaries and wages, commissions, contract labor, sales, marketing and promotion, and other related overhead expense categories. Since we currently recognize revenue over the term of the consulting and professional services engagements or any software subscriptions, we expect to experience a delay between increases in selling and marketing expenses and the recognition of revenue. We expect to continue to incur significant sales and marketing expenses in both absolute dollars and as a percentage of expenses as we seek to increase the level of our sales and marketing activities. We expect that total general and administrative expenses will increase as we continue to add resources in connection with the growth of our business.

Results of Operations

					Change from		Percent Change
Revenue	2019		2018		Prior Year		from Prior Year
Three Months Ended March 31,	$	1,010,328	$	613,854	$	396,474		65	%

Overall, the 65% increase in revenue was attributed to a 74% increase in consulting services revenue for the three months ended March 31, 2019 compared to the same period in 2018. The increase in consulting services revenue from $556,236 in the first quarter of 2018 to $965,913 for the three months ended March 31, 2019 was primarily the result of increased revenues from both new clients as well as from existing clients. We continued in the first quarter of 2019 to focus on sales and marketing efforts for consulting services which we believe allowed us to attract new clients and cross-sell add-on services to our existing clients during that quarter. The increase in consulting services revenue was partially offset by a 23% decrease in product and other revenue for the three months ended March 31, 2019 compared to the same period in 2018. The decrease in product and other revenue from $57,618 to $44,415 for the three months ended March 31, 2018 and 2019, respectively, was primarily the result of our suspension of each of Touchpoint Mapping and McorpCX | Persona in 2018 combined with a decrease in reimbursable expense income during the current quarter compared to the same quarter of 2018 mostly resulting from less travel required to execute the projects during the current quarter compared to the same quarter in 2018.

					Change from		Percent Change
Cost of Goods Sold	2019		2018		Prior Year		from Prior Year
Three Months Ended March 31,	$	388,400	$	297,415	$	90,985		31	%

Cost of goods sold increased by $90,985 for the three months ended March 31, 2019, compared to the same period in 2018 due primarily to increased resources required to support the increase in consulting services revenue provided during the current three month period. In the three months ended March 31, 2019, our labor costs increased by $56,713 compared to the same period in the prior year mainly as a result of the Company’s need to contract outside services to assist with delivery of our consulting services in 2019. There was also an increase in non-reimbursable expenses of $28,205 for the three month period ended March 31, 2019 compared to the same periods in the prior year, which was mostly related to an increase in project expenses associated with the delivery of one large client project. The remaining increase was due to increases in other expenses to support higher level of revenue.

						Change from		Percent Change
Net Operating Income (Loss)	2019		2018			Prior Year		from Prior Year
Three Months Ended March 31,	$	10,508	$	(198,803	)	$	209,311		105	%

For the three months ended March 31, 2019 we had net operating income of $10,508 compared to a net operating loss of $198,803 for the three months ended March 31, 2018. The net operating income in the current quarter was primarily a result of increased total revenues partially offset by increased labor costs and increased salaries and wages when compared to the same period in 2018. During the current quarter we focused on growing our consulting services operations through increased business development activities which we believe resulted in a 97% increase in gross profit for the three months ended March 31, 2019 compared to the same period in 2018. EBITDA increased by $206,058 to a gain of $56,157 for the three months ended March 31, 2019 compared to a loss of $149,901 for the three months ended March 31, 2018.

The following table provides a reconciliation of net income (loss) to EBITDA for the periods indicated:

	Three Months Ended
	March 31,
	2019		2018

Net Income (Loss)	$	4,777	$	(202,716	)
Depreciation and Amortization		50,149		52,705
Interest expense		1,231		110
EBITDA	$	56,157	$	(149,901	)

					Change from		Percent Change
Salaries and Wages	2019		2018		Prior Year		from Prior Year
Three Months Ended March 31,	$	293,710	$	218,959	$	74,751		34	%

Salaries and wages increased by $74,751 during the three months ended March 31, 2019 compared to the same period in 2018 mostly as a result of an increase in commissions of $54,536, combined with increased executive salaries that mostly resulted from an increase in the number of executive officers in connection with our corporate restructuring in August 2018.

We did not incur any software development costs for the three months ended March 31, 2019 primarily due to the decision to curtail additional software development halfway through 2017.

					Change from			Percent Change
Contract Services	2019		2018		Prior Year			from Prior Year
Three Months Ended March 31,	$	42,180	$	74,065	$	(31,885	)		(43%	)

Contract services expenses decreased during the three months ended March 31, 2019 compared to the same periods in 2018 primarily due to finance and administration services provided by contractors in the first quarter of 2018, which were not required in the first quarter of 2019.

					Change from		Percent Change
Other General and Administrative	2019		2018		Prior Year		from Prior Year
Three Months Ended March 31,	$	275,530	$	222,218	$	53,312		24	%

Other general and administrative costs increased $53,312 during the three months ended March 31, 2019 compared to the same period in 2018 as a result of an increase in sales, marketing and promotion costs of $50,004 compared to same period in the prior year.

							Change from			Percent Change
Other Expense	2019			2018			Prior Year			from Prior Year
Three Months Ended March 31,	$	(4,500	)	$	(3,803	)	$	(697	)		18	%

Other expense increased for the three months ended March 31, 2019, mostly as a result of increase in state and municipal tax expenses for the year to date period.

Liquidity and Capital Resources

We measure our liquidity in a variety of ways, including the following:

	March 31,		December 31,
	2019		2018
Cash and cash equivalents	$	1,582,935	$	1,350,014
Working capital	$	1,394,292	$	1,348,700

Anticipated Uses of Cash

For the three months ended March 31, 2019 and the year ended December 31, 2018, we were able to finance our operations with cash generated through operating activities, and cash on hand. The accompanying financial statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

In 2018, our primary area of investment was professional staff to support our consulting services, including client relationship management, software maintenance costs during the first half of 2018 and staff for administration, sales and marketing activities.

During the three months ended March 31, 2019, our primary uses of cash included cash paid to professional staff to support our consulting services, general and administrative support and new business development activities. We implemented plans at the start of 2019 with the goal of reducing our administrative and operating expenses and focused on increasing our gross profit received from consulting services primarily by increasing the number of consulting service contracts combined with seeking lower cost resources to assist us in providing services under such contracts.

We currently plan to fund our expenditures with cash flows generated from ongoing operations and/or if needed, the possibility may exist to raise additional capital through debt financing and/or through sales of common stock. We do not intend to pay dividends in the foreseeable future. Based upon the current level of our pipeline of signed contracts and pipeline of potential new projects plus our current expectations for future periods in light of the current economic environment, we believe that cash flow from operations and available cash will be adequate to finance the capital requirements for our business during the next 12 months.

We continue to seek ways to expand upon our business and as such, in the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources may be required. Depending on the size of a transaction, the capital resources that may be required can be substantial. The necessary resources may be generated from cash flow from operations, cash on hand, borrowing against our assets or the issuance of securities, and there is no assurance these capital resources will be available to us when required.

Cash Flow – Three months Ended March 31, 2019 and 2018

Operating Activities. Net cash provided by operating activities increased to $232,921 for the three months ended March 31, 2019 compared to net cash used in operating activities of $117,857 for the three months ended March 31, 2018, mostly as a result of the change from a net loss of $202,716 for the three months ended March 31, 2018 to net income of $4,777 for the three months ended March 31, 2019, combined with a $156,136 increase in deferred revenue, $28,270 increase in other assets, and $8,369 increase in accounts payable and accrued liabilities during the current quarter compared to the same quarter of 2018, being partially offset by an increase of $54,325 in cash used in connection with increased accounts receivables in the first three months of 2019 compared to the first three months of 2018.

Days Sales Outstanding (“DSO”), which the Company defines as the average number of days it takes to collect revenue once a sale has been made, decreased in the first three months of 2019 compared to the same period of the prior year. During the three months ended March 31, 2019, DSO was approximately 34 days, down from approximately 38 days during three months ended March 31, 2018. This decrease was largely attributed to the increase in sales that outpaced the increase in accounts receivable. DSO can fluctuate due to the timing and nature of contracts that lead to up-front billings related to deferred revenue on services not yet performed.

Investing Activities. There was no cash provided by, or used in, investing activities for three months ended March 31, 2019 and 2018.

Financing Activities. There was no cash provided by, or used in, financing activities for the three months ended March 31, 2019. Net cash used in financing activities for three months ended March 31, 2018 amounted to $8,169 which related to the repayment of a $100,000 CAD note during the period.

Off Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of March 31, 2019.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and as such, are not required to provide the associated information under this item.

ITEM 4.

CONTROLS AND PROCEDURES.

Disclosure Controls and Procedure

Pursuant to Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s management concluded that, as of the period covered by this report, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

It should be noted that any system of controls is based in part upon certain assumptions designed to obtain reasonable (and not absolute) assurance as to its effectiveness, and there can be no assurance that any design will succeed in achieving its stated goals.

Changes in Internal Controls

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS.

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

ITEM 1A.

RISK FACTORS.

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report”), which could materially affect our business, results of operations or financial condition.

The risk factors affecting the Company have not materially changed as of March 31, 2019 from those disclosed in the 2018 Annual Report. However, it is important to note that the risks described in our 2018 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may eventually prove to materially adversely affect our business, results of operations or financial condition.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Recent Sales of Unregistered Securities

There were no unregistered sales of our equity securities during the three-month period ended on March 31, 2019.

Purchases of Equity Securities

During the three months ended March 31, 2019, there were no purchases of our common stock made by, or on behalf of, the Company or any "affiliated purchaser," as defined by Rule 10b-18 of the Exchange Act.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION.

(a)	Not applicable.

ITEM 6.

EXHIBITS.

3.1	Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.2	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.3	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.4	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).
3.5	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).
3.6	Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
32.1*	Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*	Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension – Schema
101.CAL	XBRL Taxonomy Extension – Calculations
101.DEF	XBRL Taxonomy Extension – Definitions
101.LAB	XBRL Taxonomy Extension – Labels
101.PRE	XBRL Taxonomy Extension – Presentation

*Furnished, not filed

Notes to Exhibits List:

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report has been signed on its behalf by the undersigned, thereunto duly authorized on this 15th day of May 2019.

	MCORPCX, INC.


	BY:	/s/Gregg Budoi
		Gregg Budoi
		Chief Executive Officer

	BY:	/s/Tricia Tomko
		Tricia Tomko
		Chief Financial Officer

EXHIBIT INDEX

3.1	Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.2	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.3	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.4	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).
3.5	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).
3.6	Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
32.1*	Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*	Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension - Schema
101.CAL	XBRL Taxonomy Extension - Calculations
101.DEF	XBRL Taxonomy Extension - Definitions
101.LAB	XBRL Taxonomy Extension - Labels
101.PRE	XBRL Taxonomy Extension - Presentation

*Furnished, not filed

Notes to Exhibits List:

EX-31.1 2 ex_144552.htm EXHIBIT 31.1 ex_144552.htm

Exhibit 31.1

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Gregg Budoi, certify that:

1.	I have reviewed this Form 10-Q for the quarterly period ended March 31, 2019 of MCorpCX, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 15, 2019	/s/ Gregg Budoi
		Gregg Budoi
		Chief Executive Officer

EX-31.2 3 ex_144553.htm EXHIBIT 31.2 ex_144553.htm

Exhibit 31.2

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Tricia Tomko, certify that:

1.	I have reviewed this Form 10-Q for the quarterly period ended March 31, 2019 of MCorpCX, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 15, 2019	/s/ Tricia Tomko
		Tricia Tomko
		Chief Financial Officer

EX-32.1 4 ex_144554.htm EXHIBIT 32.1 ex_144554.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of MCorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregg Budoi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15^th day of May, 2019.

	/s/ Gregg Budoi
	Gregg Budoi
	Chief Executive Officer

EX-32.2 5 ex_144555.htm EXHIBIT 32.2 ex_144555.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of MCorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tricia Tomko, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15^th day of May, 2019.

	/s/ Tricia Tomko
	Tricia Tomko
	Chief Financial Officer

EX-101.INS 6 mccx-20190331.xml XBRL INSTANCE DOCUMENT false --12-31 Q1 2019 2019-03-31 10-Q 0001535079 20426158 Yes false Non-accelerated Filer McorpCX, Inc. true mccx P3Y

321580

220576

382372

343036

6470349

6454791

3087

15558

1350000

2211968

1964968

1965307

1693050

42685

48458

66283

108968

1582935

1350014

1616076

1490050

232921

-126026

500000000

20426158

0.35

0.32

0.16

0.26

0.15

0.1

0.26

0.25

0.08

0.07

218814

122238

75105

73766

258152

201439

130248

95976

388400

297415

50148

52705

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5:</div> Stock-Based Compensation</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Our stock-based compensation plan was originally established in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008.</div> The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of any outstanding issue or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500,000</div> shares, whichever was the lower amount.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2015, </div>we adopted a revised share option plan in which Plan Shares cannot exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 10, 2016.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110.</div> The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div> stock options were exercisable and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,558</div> of total compensation cost related to share-based compensation grants had been recognized for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019. </div>Unrecognized compensation expense from stock options was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$150,041</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019, </div>which is expected to be recognized over a weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.38</div> years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 1, 2019.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The following table summarizes our stock option activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019:</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 1%; margin-left: 1%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Aggregate</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Term (in years)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div></div>

-0.01

P2Y138D

150041

275530

222218

621928

316439

4777

-202716

101004

92635

39336

-14989

96576

-59560

146

-9273

18997

1231

110

1231

110

571015

344350

2211968

1964968

571015

344350

-8169

232921

-117857

4777

-202716

4777

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> “Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)” (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02”</div>) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> and these additional ASUs are now codified as Accounting Standards Codification Standard <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> - “Leases” (“ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842”</div>). ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> supersedes the lease accounting guidance in Accounting Standards Codification <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840</div> “Leases” (“ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840”</div>) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019, </div>the impact of the adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$34</div> thousand. As the right of use asset and the lease payable obligation were the same upon adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> cumulative effect impact on the Company’s retained earnings.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220,</div> Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>and interim periods within those fiscal years. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019. </div>The adoption of this standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the consolidated financial statements.</div></div></div>

611420

515242

10508

-198803

34000

28939

5225

34000

90935

72876

1682

1536

-4500

-3803

42180

74065

89443

90074

8169

-4829396

-4834173

965913

556236

44415

57618

1010328

613854

218814

P1Y

34164

293710

218959

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months ended</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">March 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="border-bottom: 1px none rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,777</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(202,716</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic and diluted weighted average common shares outstanding</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share, basic and diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 1%; margin-left: 1%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Aggregate</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Term (in years)</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin: 0pt auto 0pt 0pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Largest client</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Second largest client</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Third largest client</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Next three largest clients</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">All other clients</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table></div>

15558

3087

2500000

1350000

0.60

2040000

0.47

0.3

0.1

P10Y

P4Y302D

P6Y229D

P6Y135D

1640953

1620618

6428997

-4422957

2006040

6432084

-4625673

1806411

6454791

-4834173

6470349

-4829396

20426158

xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0001535079 2016-08-10 2016-08-10 0001535079 us-gaap:EmployeeStockOptionMember 2016-08-10 2016-08-10 0001535079 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2018-01-01 2018-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2018-01-01 2018-03-31 0001535079 us-gaap:ProductAndServiceOtherMember 2018-01-01 2018-03-31 0001535079 us-gaap:ProductMember 2018-01-01 2018-03-31 0001535079 us-gaap:ServiceMember 2018-01-01 2018-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001535079 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001535079 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001535079 2018-01-01 2018-12-31 0001535079 2019-01-01 2019-03-31 0001535079 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2019-01-01 2019-03-31 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2019-01-01 2019-03-31 0001535079 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-03-31 0001535079 us-gaap:ProductMember 2019-01-01 2019-03-31 0001535079 us-gaap:ServiceMember 2019-01-01 2019-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001535079 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001535079 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001535079 2017-12-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001535079 us-gaap:CommonStockMember 2017-12-31 0001535079 us-gaap:RetainedEarningsMember 2017-12-31 0001535079 2018-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001535079 us-gaap:CommonStockMember 2018-03-31 0001535079 us-gaap:RetainedEarningsMember 2018-03-31 0001535079 2018-12-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001535079 us-gaap:CommonStockMember 2018-12-31 0001535079 us-gaap:RetainedEarningsMember 2018-12-31 0001535079 2019-01-01 0001535079 2019-03-31 0001535079

2019-04-01

2019-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001535079 us-gaap:CommonStockMember 2019-03-31 0001535079 us-gaap:RetainedEarningsMember 2019-03-31 0001535079 2019-05-13

EX-101.SCH 7 mccx-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Revenues link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Capitalized Software Development Costs link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Concentrations link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Going Concern link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 5 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 6 - Concentrations (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 2 - Recent Accounting Pronouncements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 3 - Revenues 1 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Revenues 2 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 5 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Stock-based Compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 6 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 7 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 mccx-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 mccx-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 mccx-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual Accounts payable and accrued liabilities us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Significant Accounting Policies Note 5 - Stock-based Compensation Contract services Additional Paid-in Capital [Member] Note 6 - Concentrations Note 8 - Basic and Diluted Net Income / (Loss) Per Share Common Stock [Member] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (loss) before income taxes Note 5 - Stock-based Compensation - Stock Option Activity (Details) Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Income tax provision Note 8 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Notes To Financial Statements Equity Components [Axis] Notes To Financial Statements [Abstract] Equity Component [Domain] Stock compensation expense Other assets, net us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period us-gaap_RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount Other current liabilities Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Expenses us-gaap_OperatingExpenses Total expenses Share-based Payment Arrangement, Activity [Table Text Block] Other general and administrative Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Depreciation and amortization Other current liabilities us-gaap_IncreaseDecreaseInOtherCurrentLiabilities Second Largest Client [Member] Represents the second largest client. Largest Client [Member] Represents the largest client. Next Three Largest Clients [Member] Represents the next three largest clients. Third Largest Client [member] Represents the third largest client. us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense All Other Clients [Member] Represents the all other clients. us-gaap_AssetsCurrent Total current assets Weighted average exercise price, options exercisable (in dollars per share) Long term assets: Weighted average remaining contractual term, options exercisable (Year) Aggregate intrinsic value, options exercisable Revenue from Contract with Customer [Text Block] Options exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average remaining contractual term, outstanding balance (Year) Aggregate intrinsic value, outstanding balance Amendment Flag Accounting Policies [Abstract] New Accounting Pronouncements, Policy [Policy Text Block] Concentration Risk Disclosure [Text Block] Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2019 and December 31, 2018 Adjustments to reconcile net income (loss) to net cash provided by (used in) operations: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Weighted average exercise price, outstanding balance (in dollars per share) Weighted average exercise price, outstanding balance (in dollars per share) Common stock, shares authorized (in shares) Deferred revenue us-gaap_IncreaseDecreaseInContractWithCustomerLiability Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Accounts payable and accrued liabilities Common stock, shares issued (in shares) Deferred revenue Weighted average exercise price, options forfeited or expired (in dollars per share) Common stock, par value (in dollars per share) Weighted average exercise price, options granted (in dollars per share) Current Fiscal Year End Date Weighted average exercise price, options exercised (in dollars per share) us-gaap_OperatingLeasePayments Lease liability Document Fiscal Period Focus Document Fiscal Year Focus Product and Service [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding, balance (in shares) Options outstanding, balance (in shares) Document Period End Date ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02 Product and Service [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Options forfeited or expired (in shares) Entity Emerging Growth Company Document Type Entity Small Business us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Interest paid us-gaap_PolicyTextBlockAbstract Accounting Policies Document Information [Line Items] Document Information [Table] Service [Member] Entity Filer Category Entity Current Reporting Status us-gaap_CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax Revenue, net Capitalized software development costs, net Capitalized Computer Software, Net, Ending Balance Weighted average common shares outstanding-basic and diluted (in shares) Basic and diluted weighted average common shares outstanding (in shares) us-gaap_RepaymentsOfNotesPayable Repayment of notes payable us-gaap_CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Customer [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Customer [Domain] Concentrations us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Product and Service, Other [Member] Net income (loss) per share-basic and diluted (in dollars per share) Net income (loss) per share, basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Liabilities: Stock based compensation - stock options Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] Statement [Table] Product [Member] Statement of Financial Position [Abstract] Supplemental disclosure of cash flow information: us-gaap_Assets Total assets us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Concentration Risk Type [Axis] CASH FLOWS FROM OPERATING ACTIVITIES: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition us-gaap_AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss, Ending Balance Concentration Risk Type [Domain] Statement of Cash Flows [Abstract] Statement [Line Items] Entity Common Stock, Shares Outstanding (in shares) Statement of Stockholders' Equity [Abstract] Accounts receivable Income Statement [Abstract] Revenue Benchmark [Member] Revenue, net Share-based Payment Arrangement [Text Block] us-gaap_IncreaseDecreaseInOtherNoncurrentAssets Other assets Additional paid-in capital Shareholders' equity: Trading Symbol Concentration Risk Benchmark [Axis] Other expense Concentration Risk Benchmark [Domain] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Award Type [Domain] Current assets: mccx_CapitalizedComputerSoftwareUsefulLife Capitalized Computer Software, Useful Life The useful life of capitalized computer software. Award Type [Axis] Net income (loss) Net income (loss) Net income (loss) us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Options exercised (in shares) us-gaap_TableTextBlock Notes Tables us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities us-gaap_Liabilities Total liabilities New Accounting Pronouncements and Changes in Accounting Principles [Text Block] us-gaap_OperatingIncomeLoss Net operating income (loss) us-gaap_ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized Share-based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by (used in) operating activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Increase (decrease) in cash and cash equivalents us-gaap_GrossProfit Gross profit us-gaap_CostOfGoodsAndServicesSold Cost of goods sold FINANCING ACTIVITIES Options granted (in shares) Property and equipment, net us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders' equity Labor Accumulated deficit Research, Development, and Computer Software Disclosure [Text Block] us-gaap_InterestExpense Interest expense Changes in operating assets and liabilities: us-gaap_StockholdersEquity Total shareholders' equity Balance Balance Cost of goods sold us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] Class of Stock [Axis] us-gaap_OperatingLeaseLiability Operating Lease, Liability, Total Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Lease payable us-gaap_OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset Retained Earnings [Member] Earnings Per Share [Text Block] Salaries and wages EX-101.PRE 11 mccx-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2019	May 13, 2019
Document Information [Line Items]
Entity Registrant Name	McorpCX, Inc.
Entity Central Index Key	0001535079
Trading Symbol	mccx
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		20,426,158
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 1,582,935	$ 1,350,014
Accounts receivable	382,372	343,036
Total current assets	1,965,307	1,693,050
Long term assets:
Property and equipment, net	89,443	90,074
Capitalized software development costs, net	66,283	108,968
Other assets, net	90,935	72,876
Total assets	2,211,968	1,964,968
Liabilities:
Accounts payable and accrued liabilities	321,580	220,576
Deferred revenue	218,814	122,238
Lease payable	28,939
Other current liabilities	1,682	1,536
Total current liabilities	571,015	344,350
Total liabilities	571,015	344,350
Shareholders' equity:
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2019 and December 31, 2018
Additional paid-in capital	6,470,349	6,454,791
Accumulated deficit	(4,829,396)	(4,834,173)
Total shareholders' equity	1,640,953	1,620,618
Total liabilities and shareholders' equity	$ 2,211,968	$ 1,964,968

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares $ / shares in Thousands	Mar. 31, 2019	Dec. 31, 2018
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	20,426,158	20,426,158
Common stock, shares outstanding (in shares)	20,426,158	20,426,158

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue, net
Revenue, net	$ 1,010,328	$ 613,854
Cost of goods sold
Cost of goods sold	388,400	297,415
Gross profit	621,928	316,439
Expenses
Salaries and wages	293,710	218,959
Contract services	42,180	74,065
Other general and administrative	275,530	222,218
Total expenses	611,420	515,242
Net operating income (loss)	10,508	(198,803)
Interest expense	(1,231)	(110)
Other expense	(4,500)	(3,803)
Income (loss) before income taxes	4,777	(202,716)
Income tax provision
Net income (loss)	$ 4,777	$ (202,716)
Net income (loss) per share-basic and diluted (in dollars per share)	$ 0	$ (0.01)
Weighted average common shares outstanding-basic and diluted (in shares)	20,426,158	20,426,158
Service [Member]
Revenue, net
Revenue, net	$ 965,913	$ 556,236
Product and Service, Other [Member]
Revenue, net
Revenue, net	44,415	57,618
Cost of goods sold
Cost of goods sold	130,248	95,976
Product [Member]
Cost of goods sold
Labor	$ 258,152	$ 201,439

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2017	20,426,158
Balance at Dec. 31, 2017		$ 6,428,997	$ (4,422,957)	$ 2,006,040
Stock based compensation - stock options		3,087		3,087
Net income (loss)			(202,716)	(202,716)
Balance (in shares) at Mar. 31, 2018	20,426,158
Balance at Mar. 31, 2018		6,432,084	(4,625,673)	$ 1,806,411
Balance (in shares) at Dec. 31, 2018	20,426,158			20,426,158
Balance at Dec. 31, 2018		6,454,791	(4,834,173)	$ 1,620,618
Stock based compensation - stock options		15,558		15,558
Net income (loss)			4,777	$ 4,777
Balance (in shares) at Mar. 31, 2019	20,426,158			20,426,158
Balance at Mar. 31, 2019		$ 6,470,349	$ (4,829,396)	$ 1,640,953

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 4,777	$ (202,716)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:
Depreciation and amortization	50,148	52,705
Stock compensation expense	15,558	3,087
Changes in operating assets and liabilities:
Accounts receivable	(39,336)	14,989
Other assets	9,273	(18,997)
Accounts payable and accrued liabilities	101,004	92,635
Lease liability	(5,225)
Other current liabilities	146
Deferred revenue	96,576	(59,560)
Net cash provided by (used in) operating activities	232,921	(117,857)
FINANCING ACTIVITIES
Repayment of notes payable		(8,169)
Net cash used in financing activities		(8,169)
Increase (decrease) in cash and cash equivalents	232,921	(126,026)
Cash and cash equivalents, beginning of period	1,350,014	1,616,076
Cash and cash equivalents, end of period	1,582,935	1,490,050
Supplemental disclosure of cash flow information:
Interest paid	1,231	110
ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02	$ 34,164

XML 18 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Organization and Basis of Presentation	3 Months Ended
Note 1 - Organization and Basis of Presentation	Mar. 31, 2019
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1: Organization and Basis of Presentation McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on December 14, 2001. We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc. The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on December 14, 2017. On August 16, 2018, the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company. We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization. The consolidated financial statements and related disclosures as of and for the three months ended March 31, 2019 and 2018, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2018 was derived from the audited consolidated financial statements included in our Annual Report on Form 10 -K for the year ended December 31, 2018. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2018, filed on Form 10 -K with the SEC on April 1, 2019. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the full year.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Recent Accounting Pronouncements	3 Months Ended
Note 2 - Recent Accounting Pronouncements	Mar. 31, 2019
Notes to Financial Statements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	Note 2: Recent Accounting Pronouncements In February 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016 - 02, “Leases (Topic 842 )” (“ASU 2016 - 02” ) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU 2016 - 02 to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU 2016 - 02 and these additional ASUs are now codified as Accounting Standards Codification Standard 842 - “Leases” (“ASC 842” ). ASC 842 supersedes the lease accounting guidance in Accounting Standards Codification 840 “Leases” (“ASC 840” ) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC 842 are not adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on January 1, 2019, the impact of the adoption of ASC 842 resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately $34 thousand. As the right of use asset and the lease payable obligation were the same upon adoption of ASC 842, there was no cumulative effect impact on the Company’s retained earnings. In February 2018, the FASB issued ASU 2018 - 02, Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC 220, Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018 - 02 effective January 1, 2019. The adoption of this standard did not have a material impact on the consolidated financial statements.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Revenues	3 Months Ended
Note 3 - Revenues	Mar. 31, 2019
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 3. Revenues Consulting Service Revenues The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the customer experience being analyzed. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has no alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract. Product and other revenue Product and other revenue during 2018 and 2019 has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are not subject to the licensing guidance in Topic 606 because the customer can’t take possession of the software at any time and the customer would not be able to operate the software on its own or with another third party. Fees charged to customers of Touchpoint Mapping may include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does not affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do not unbundle such services into separate performance obligations as their pattern of transfer does not differ. Deferred Revenues (Contract Liabilities) The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable. Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer. The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is $218,814 as of March 31, 2019 and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of $218,814 in 2019 related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is not expected to be recognized beyond fiscal year 2019. During the three months ended March 31, 2019, we recognized revenue of $75,105, related to our contract liabilities included in deferred revenue at December 31, 2018. During the three months ended March 31, 2018 we recognized revenue of $73,766, related to our contract liabilities included in deferred revenue at December 31, 2017. Practical Expedients and Exemptions Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Capitalized Software Development Costs	3 Months Ended
Note 4 - Capitalized Software Development Costs	Mar. 31, 2019
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	Note 4: Capitalized Software Development Costs Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. There were no capitalizable costs during the three months ended March 31, 2019 and 2018. Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the three -year expected useful life of the software. Capitalized software development costs, net of amortization, were $66,283 and $108,968 as of March 31, 2019 and December 31, 2018, respectively. Amortization expense incurred during the three months ended March 31, 2019 and 2018 was $42,685 and $48,458, respectively, and is included in cost of goods sold in the consolidated statements of operations.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Stock-based Compensation

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

Note

Stock-Based Compensation

Our stock-based compensation plan was originally established in

2008.

The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could

not

exceed

30%

of any outstanding issue or

2,500,000

shares, whichever was the lower amount.

December 2015,

we adopted a revised share option plan in which Plan Shares cannot exceed

10%

of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a

-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on

August 10, 2016.

No.

110.

The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

March 31, 2019,

1,350,000

stock options were exercisable and

$15,558

of total compensation cost related to share-based compensation grants had been recognized for the

three

months ended

March 31, 2019.

Unrecognized compensation expense from stock options was

$150,041

March 31, 2019,

which is expected to be recognized over a weighted-average vesting period of

2.38

years beginning

April 1, 2019.

The following table summarizes our stock option activity for the

three

months ended

March 31, 2019:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2018		2,040,000	$	0.47		6.63		-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2019		2,040,000	$	0.47		6.37		-

Exercisable at March 31, 2019		1,350,000	$	0.60		4.83	$	-

XML 23 R12.htm IDEA: XBRL DOCUMENT

Note 6 - Concentrations

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

Note

Concentrations

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune

500

companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the

three

months ended

March 31, 2019

and

2018,

the percentage of sales and the concentrations are:

	2019			2018
Largest client		35	%		32	%
Second largest client		16	%		26	%
Third largest client		15	%		10	%
Next three largest clients		26	%		25	%
All other clients		8	%		7	%
		100	%		100	%

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is

provision made to include an allowance for doubtful accounts.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Going Concern	3 Months Ended
Note 7 - Going Concern	Mar. 31, 2019
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	Note 7: Going Concern The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. We have had material operating losses and have not yet created positive cash flows for a full year. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to increase our net operating income. We believe that our increased revenues in the year ended December 31, 2018 and three months ended March 31, 2019 compared to our financial results for the year ended December 31 2017 and the first quarter of 2018, coupled with our cash balance of $1,582,935 at March 31, 2019, and our belief that sufficient funding may be available from private placements of equity securities or additional borrowings if needed; will enable us to meet our liquidity needs over the next 12 months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing debt, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Basic and Diluted Net Income / (Loss) Per Share

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Earnings Per Share [Text Block]

Note

Basic and Diluted Net Income / (Loss) per Share

three

months ended

March 31, 2019

and

2018,

the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income / (loss) per share basic and diluted are equal in all periods presented. Securities that were

not

included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of

1,350,000

for the

three

months ended

March 31, 2019

and

2018.

	Three Months ended
	March 31,
	2019		2018
Net income (loss)	$	4,777	$	(202,716	)
Basic and diluted weighted average common shares outstanding		20,426,158		20,426,158

Net income (loss) per share, basic and diluted	$	0.00	$	(0.01	)

XML 26 R15.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	3 Months Ended
Significant Accounting Policies (Policies)	Mar. 31, 2019
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	In February 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016 - 02, “Leases (Topic 842 )” (“ASU 2016 - 02” ) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU 2016 - 02 to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU 2016 - 02 and these additional ASUs are now codified as Accounting Standards Codification Standard 842 - “Leases” (“ASC 842” ). ASC 842 supersedes the lease accounting guidance in Accounting Standards Codification 840 “Leases” (“ASC 840” ) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC 842 are not adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on January 1, 2019, the impact of the adoption of ASC 842 resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately $34 thousand. As the right of use asset and the lease payable obligation were the same upon adoption of ASC 842, there was no cumulative effect impact on the Company’s retained earnings. In February 2018, the FASB issued ASU 2018 - 02, Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC 220, Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018 - 02 effective January 1, 2019. The adoption of this standard did not have a material impact on the consolidated financial statements.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Note 5 - Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Notes Tables

Share-based Payment Arrangement, Activity [Table Text Block]

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2018		2,040,000	$	0.47		6.63		-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2019		2,040,000	$	0.47		6.37		-

Exercisable at March 31, 2019		1,350,000	$	0.60		4.83	$	-

XML 28 R17.htm IDEA: XBRL DOCUMENT

Note 6 - Concentrations (Tables)

3 Months Ended

Mar. 31, 2019

Notes Tables

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	2019			2018
Largest client		35	%		32	%
Second largest client		16	%		26	%
Third largest client		15	%		10	%
Next three largest clients		26	%		25	%
All other clients		8	%		7	%
		100	%		100	%

XML 29 R18.htm IDEA: XBRL DOCUMENT

Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months ended
	March 31,
	2019		2018
Net income (loss)	$	4,777	$	(202,716	)
Basic and diluted weighted average common shares outstanding		20,426,158		20,426,158

Net income (loss) per share, basic and diluted	$	0.00	$	(0.01	)

XML 30 R19.htm IDEA: XBRL DOCUMENT

Note 2 - Recent Accounting Pronouncements (Details Textual) $ in Thousands	Jan. 01, 2019 USD ($)
Operating Lease, Right-of-Use Asset	$ 34
Operating Lease, Liability, Total	$ 34

XML 31 R20.htm IDEA: XBRL DOCUMENT

Note 3 - Revenues 1 (Details Textual) - USD ($)	3 Months Ended
Note 3 - Revenues 1 (Details Textual) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Revenue, Remaining Performance Obligation, Amount	$ 218,814
Contract with Customer, Liability, Revenue Recognized	$ 75,105	$ 73,766

XML 32 R21.htm IDEA: XBRL DOCUMENT

Note 3 - Revenues 2 (Details Textual)	Mar. 31, 2019 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 218,814
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-04-01
Revenue, Remaining Performance Obligation, Amount	$ 218,814
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year

XML 33 R22.htm IDEA: XBRL DOCUMENT

Note 4 - Capitalized Software Development Costs (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Capitalized Computer Software, Additions	$ 0	$ 0
Capitalized Computer Software, Useful Life	3 years
Capitalized Computer Software, Net, Ending Balance	$ 66,283		$ 108,968
Capitalized Computer Software, Amortization	$ 42,685	$ 48,458

XML 34 R23.htm IDEA: XBRL DOCUMENT

Note 5 - Stock-based Compensation (Details Textual) - USD ($)		3 Months Ended
	Aug. 10, 2016	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	10.00%	30.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		1,350,000
Share-based Payment Arrangement, Expense		$ 15,558
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount		$ 150,041
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition		2 years 138 days

XML 35 R24.htm IDEA: XBRL DOCUMENT

Note 5 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Options outstanding, balance (in shares)	2,040,000
Weighted average exercise price, outstanding balance (in dollars per share)	$ 0.47
Weighted average remaining contractual term, outstanding balance (Year)	6 years 135 days	6 years 229 days
Aggregate intrinsic value, outstanding balance
Options granted (in shares)
Weighted average exercise price, options granted (in dollars per share)
Options exercised (in shares)
Weighted average exercise price, options exercised (in dollars per share)
Options forfeited or expired (in shares)
Weighted average exercise price, options forfeited or expired (in dollars per share)
Options outstanding, balance (in shares)	2,040,000	2,040,000
Weighted average exercise price, outstanding balance (in dollars per share)	$ 0.47	$ 0.47
Options exercisable (in shares)	1,350,000
Weighted average exercise price, options exercisable (in dollars per share)	$ 0.60
Weighted average remaining contractual term, options exercisable (Year)	4 years 302 days
Aggregate intrinsic value, options exercisable

XML 36 R25.htm IDEA: XBRL DOCUMENT

Note 6 - Concentrations (Details Textual) $ in Thousands	Mar. 31, 2019 USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 0

XML 37 R26.htm IDEA: XBRL DOCUMENT

Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Concentrations	100.00%	100.00%
Largest Client [Member]
Concentrations	35.00%	32.00%
Second Largest Client [Member]
Concentrations	16.00%	26.00%
Third Largest Client [member]
Concentrations	15.00%	10.00%
Next Three Largest Clients [Member]
Concentrations	26.00%	25.00%
All Other Clients [Member]
Concentrations	8.00%	7.00%

XML 38 R27.htm IDEA: XBRL DOCUMENT

Note 7 - Going Concern (Details Textual) - USD ($)	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 1,582,935	$ 1,350,014	$ 1,490,050	$ 1,616,076

XML 39 R28.htm IDEA: XBRL DOCUMENT

Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,350,000	1,350,000

XML 40 R29.htm IDEA: XBRL DOCUMENT

Note 8 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net income (loss)	$ 4,777	$ (202,716)
Basic and diluted weighted average common shares outstanding (in shares)	20,426,158	20,426,158
Net income (loss) per share, basic and diluted (in dollars per share)	$ 0	$ (0.01)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
&PO=V]R:W-H965TL!CKNW'V#7\SK_ >[EG',_ MN&0#FE?; CCRIJ2V.6V=ZXZ,V;(%Q>T-=J#]38U&<>=-TS#;&>!5)"G)TLWF MCBDN-"VRZ#N;(L/>2:'A;(CME>+F]PDD#CE-Z+OC632M"PY69!UOX#NX']W9 M>(O-*I50H*U 30S4.;U/CJ==P$? BX#!+LXD5')!? W&ERJGFY 02"A=4.!^ MN\(#2!F$?!J_)DTZAPS$Y?E=_2G6[FNY< L/*'^*RK4Y/5!2043,5_A2M(#P^9^!@E2AM74O;6H9I4?"J*OXV[T'$?QIO;_41;)Z03(9T) MAQB'C8%BYH_<\2(S.! S]K[CX8F38^I[4P9G;$6\\\E;[[T6R7:?L6L0FC"G M$9,N,3.">?4Y1+H6XI3^1T_7Z=O5#+>1OEU&3^[6!7:K KLHL/NGQ,.'$M
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end XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 49 110 1 false 15 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.mcorpcx.com/20190331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.mcorpcx.com/20190331/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.mcorpcx.com/20190331/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.mcorpcx.com/20190331/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.mcorpcx.com/20190331/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.mcorpcx.com/20190331/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization and Basis of Presentation Sheet http://www.mcorpcx.com/20190331/role/statement-note-1-organization-and-basis-of-presentation Note 1 - Organization and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Recent Accounting Pronouncements Sheet http://www.mcorpcx.com/20190331/role/statement-note-2-recent-accounting-pronouncements Note 2 - Recent Accounting Pronouncements Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Revenues Sheet http://www.mcorpcx.com/20190331/role/statement-note-3-revenues Note 3 - Revenues Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Capitalized Software Development Costs Sheet http://www.mcorpcx.com/20190331/role/statement-note-4-capitalized-software-development-costs- Note 4 - Capitalized Software Development Costs Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Stock-based Compensation Sheet http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation Note 5 - Stock-based Compensation Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Concentrations Sheet http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations- Note 6 - Concentrations Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Going Concern Sheet http://www.mcorpcx.com/20190331/role/statement-note-7-going-concern Note 7 - Going Concern Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Basic and Diluted Net Income / (Loss) Per Share Sheet http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share Note 8 - Basic and Diluted Net Income / (Loss) Per Share Notes 14 false false R15.htm 014 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.mcorpcx.com/20190331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.mcorpcx.com/20190331/role/statement-note-2-recent-accounting-pronouncements 15 false false R16.htm 015 - Disclosure - Note 5 - Stock-based Compensation (Tables) Sheet http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation-tables Note 5 - Stock-based Compensation (Tables) Tables http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation 16 false false R17.htm 016 - Disclosure - Note 6 - Concentrations (Tables) Sheet http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations-tables Note 6 - Concentrations (Tables) Tables http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations- 17 false false R18.htm 017 - Disclosure - Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Tables) Sheet http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Tables) Tables http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share 18 false false R19.htm 018 - Disclosure - Note 2 - Recent Accounting Pronouncements (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-2-recent-accounting-pronouncements-details-textual Note 2 - Recent Accounting Pronouncements (Details Textual) Details 19 false false R20.htm 019 - Disclosure - Note 3 - Revenues 1 (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-3-revenues-1-details-textual Note 3 - Revenues 1 (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-3-revenues 20 false false R21.htm 020 - Disclosure - Note 3 - Revenues 2 (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-3-revenues-2-details-textual Note 3 - Revenues 2 (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-3-revenues 21 false false R22.htm 021 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-4-capitalized-software-development-costs-details-textual Note 4 - Capitalized Software Development Costs (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-4-capitalized-software-development-costs- 22 false false R23.htm 022 - Disclosure - Note 5 - Stock-based Compensation (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation-details-textual Note 5 - Stock-based Compensation (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation-tables 23 false false R24.htm 023 - Disclosure - Note 5 - Stock-based Compensation - Stock Option Activity (Details) Sheet http://www.mcorpcx.com/20190331/role/statement-note-5-stockbased-compensation-stock-option-activity-details Note 5 - Stock-based Compensation - Stock Option Activity (Details) Details 24 false false R25.htm 024 - Disclosure - Note 6 - Concentrations (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations-details-textual Note 6 - Concentrations (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations-tables 25 false false R26.htm 025 - Disclosure - Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Sheet http://www.mcorpcx.com/20190331/role/statement-note-6-concentrations-percentage-of-sales-and-the-concentrations-details Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Details 26 false false R27.htm 026 - Disclosure - Note 7 - Going Concern (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-7-going-concern-details-textual Note 7 - Going Concern (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-7-going-concern 27 false false R28.htm 027 - Disclosure - Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) Sheet http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-details-textual Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) Details http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables 28 false false R29.htm 028 - Disclosure - Note 8 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Sheet http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-computations-for-basic-and-diluted-net-income-loss-per-share-details Note 8 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Details http://www.mcorpcx.com/20190331/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables 29 false false All Reports Book All Reports mccx-20190331.xml mccx-20190331.xsd mccx-20190331_cal.xml mccx-20190331_def.xml mccx-20190331_lab.xml mccx-20190331_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 46 0001437749-19-010040-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-19-010040-xbrl.zip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�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
XX@:=ND:0WRNG9ZO![WP M@9'9/.76Y_UB3E _9GGOYP&A T('A X('1 Z('1 Z+I)Z!I9XHTSO$\>$XF; MXAZ?D!.;V1S%K,YM.M+GF&-PBJ( 8P/&5MO2'/#1'(J#'PJPK"QCDY4-QV<; MH^$.16(C\YEP9F1YVZ=BP-SZ+QG$,DK3T%-[3E(=4<,FU[[@"P)Y02C;/S"< MBS[T'I-B#A6*6,G5#57D<969N&#'8R(&ITG":CW;'$7;0SP@<$#@ MNL%\'%'#:CJT3V,^,;-;1+-, QF;D)8'#@KQ+Z!G0,^ G@$] WK617JFN(2; M9&,,3V(\QH&_G[F]D$7";>05.G5122;D2_YSCTM)*A]C7N$=022O3%*ZI^)#*!1H:$T: MVLA4#02UC* J#MB^F^1 3H&< CG=1$)F:!!],](5:!3T5;LP1\$2-1Y;+3T5 MRTO$D-"],D?U<1TX]JM0(B#Q5DF\UAN3,?@:K]^H31],49A&:#@N.=HA2/ C MASU;FJ39@WL]#%B8>PFI2MVF*]VAAK!J/H1^61P-365 ;\OH;747ZKO!"JP6 M6"VPVDTD2M8WTJSA9/](EUI<3?(4B\>[ #/K)C.3O"@E0J;TLFWP,"8.=]J0 M;#@6FXY/7\3/2S_@XJB2L!I/ @8&# P8F'W#8;^Y"X@7$"\@7D"\@'BI$Z_: MQE*WMR'6HV3[--'138E YCI*YO9YBTI,;_]N8B<:Z#9CRN MUM. #@(=!#IHWYQI<8(#K@A<$;@B<$7@BCI!NCVL*>-\\<2C2/#:K3T)6PFA M7H@2'T?,2[C(J1]ILL7Z#9CCBOO*"$S1&%,4)SP4'?!PGK^?A^W7LWN2C7I- M\];LD%MAONAZU\CG-@_V1SCB^)68M26E;6Y:VQ;I#D^FR7#\@Z$!8ZAL[UUE M'=B!UPVJV:\5N\Y@M\YSP*SO@$T+9GT'S/K.,GZMI:J]GM(3?$HM$N,,YP,W M[A]1G"+F'>_)950>98ZUJ$L#_ 3X21-WT&7[2?_ R?0L90F9(;H:Y7=Y3[Q# M 9G$^"\4[FA8[R$V"$SOC+0<-1A"?9."[14JDNL!M@-\!N M@-T NP%V8]]ZK[5DO4&6LY\!8Y/\G#1'?DH?987\2*0!\@/D!]C WLI=/,]1 M(*+7>,:+#,?W_%,VYC,A_XY7P"0\WD=_AHVERSGMUP:!LMQ%@E\ N M@5T"NS1#K=J-^\=9^,#1. MHVL\WC6VU2O68X1OSGE1@>4@#'%V2D19O%:AJDU>7B7?C- $_Y5-/F6N"=7J M'57QIC2OMKH2A)[!.0#. 7 .](_6]I;9 ZTM#ZG6L#'>$*NM;PZWYRSJ'$CU M[!YE@#Z\!8 J+5[COH_R@\3W$[A%]Q $JAO2&Q(^(<<0S MH=D#X7/ZYO=GA"6\R_T;)>MDM-RK?4GHXJ,JQXA9(6SVC-8TO1=S^7!>Y5TS MTG8GP%W+\QW-1HC* "DK;\'U4WSB/J5^/,EF\-.7=9%;_T5\E+VIFU0(OCBR MGPW29$IHQ3;!!]]Y_Q+)TUC9]"DYV&DI4IMC8"XO V\N,;?X8*[5\335D" M;B3O$*-=9;B-A_.S$#F*X0(ZT0M3/*4-Q1:-.9[>(.1R-:8SAL,6K;NYE'& M]*,SF-:+V2@#]\,?F?P._?/ M+]9;UR#XQ2I)G/Z:9=S6_=6;$'&G2F80TGTS>!6?9L[2U1((#%TP=!O8$\JF M@S@4_UW\7\I'>21"CX/DS*?TA7?%?_I16F9K*=4%,Q?,7#!SPPG_=W%'.XLGZ(']$]"E**$XS8Q7,0 MI;QK7?(I*M\Z#F:"89?YD9MX-MC?8'^#_0WV-]C?8'_;M[];6=+L M9US,5\FA'AE[C+,*EEFHR125Y"[LFY11OT6+>1O["@T6NS&+?1!%0_Y:Z%F$ M!4,NW&LM+]B (-<^G2"6Y(\O%Z.B6!/\A?>\!UX";353@8I2A08$XW,HB4-% MC*2%&Q#H88JIJCRRL@V(LYZ1VIN;-E4RT=[>E(C19(,.\;]VJ1#_Z,_O_G\( M7=Y+Q0KFG^I"9H046]^&XRTI"J=PI;(6@F^;[_D.LY^G* ZF,Y_^K-PHKEJM M"PJ]K&2K."]'M5HG%)*<_:-0HP-JK'Z@TO'^',%HUK=IH(ZNH)+ MG8E'P?!V_V04%:=5WSN)W)11\YCWO3O[0#&9XM+1X=&'%!=+2+S6L\H8+?69FTQ9X"SEQE^?_7A/'/Q>Z.6TH>,7^%IR\_^,1P%0_G2 S+ M>#(($OR899T-1HP/U: T^[K%IES4^=4VY_"@JWA4I\ADZ1_G_6CH6 M/\+[8$_5<\27@ !G"P#_/4*9D1"'F_>)E:BH4]6\8KL@7\7+LQ5N_1=A6PE) M@X ;+^$U]DY-"R!MNZ>1R M#AA#B::*N[4M#\X$<5*1W/HX++_BO*24>7%YXT4&Y6('UJ9!6:*)^@-L+O/J M4DIFDOH/ZHS2!61!3]F"!W3PW>K3K_H/LJ+TFA26Z_.ZC'E15_A=BSE[<<)U MFC<%\_! M5!Q$?DGH-O0R\[&!)UK(8BP\E[E$P^K"D#>J)_1P+.;62^$#E4S#*E6<28!M M2=AT/H\R0?QHB>%5/"9TE@=!)"] K[8[^;U:/1!2=-U/T349F.UH:@\$9NL% M9OJTAMO!'],) K/=84PBI$K.^9HWJS M0-UX1@MC^TN.4LQMH&11UAA8-6"H!%$ASM?"V'4)0;5X3'N#]1'1$3%]#E5; MW5 GMMY""FQ_^Z6B$[F]G%DGNJ%B^+B]-'0G4-1*JE#&4O_F1''98)^0K!][ M=&XW0!T_@W) VC&3< \X-D!5CN&U1^4L#-AFL*N?$-*>6=A;,/=)HVUO'IQG M[?/YB2;N@"I)+F_/6,S1O(A[.5/6RF5W;K-:Y0I=*YSJBA=65_DM6[HB1](5 M'^H>^#26@6-R9V"-&U6"]?'.93MG;O'3@5PG/+ZCP7?0F1GKV:J7/Y;=*UW%8]FEK46W>A=!4[3##;I\-@Z%6CD1WX<(+YD M(I$7L\B2\7(/\-[G(6D^W?RA2+4$!#]!\WZ"ADY&4LA36N2/E-CQ-9Y@3\UU M5J (G2CI557%QDE6?'CQ,>U'PJ5^%2^R,,[(;$;B^X0$/\O44:YH0:FJ R,6 M^8<6-Z?G$DAZRV:9S@@K.ZNLJJPMT3I5:E!2S0)B]<2D4]6\8O(CD3:S M5BU.JQMB2*:EBI)VQ8[#K"M/2<29(Q/CLO1@"%FUCKR)ZI[_NJ!-L4NB^-4J MJ%6RH(Q(*]]=?\MTJ"IK273E/B0I;5[\6TIXGTA>;CD+3_C8%.-Q+EAZN8&A M4L7&B3QYJLO2[(@YXB$89531C2J M0FQ5(JSBVMRMU?BU--(N(ZO@3F"WUC"!H"L$72'HVHF@:Q/,D;JX0RGMG"IXU/EP'>EM^A,,3+'NENS3(6VI Z5=J7'Z*"C$\EH M;Y+I+CX*GK#V]GM:FWO5L"F.\KK22]3F76GDP)4IMTK1 I-%.[/$EA40EPM+?7V\*JI B,/'JHC(KVH4F]0.5M']FCZL9V M9=;#1#BN4X1)#RIY(-"I=5L/'-T,)FO; M2;8OF2:YI2HV;S9[LW;5@VW?K"V7#?:/[(C5UOX11I.-V#__:S?NSS\27M P M#9(AO4?T$0>H0$99,:."9C- +@,K?-%*96UD_;+D'%,4B!/:>)O%"14EI>R( M.QQ_(R3K"?T LF+*]@\1J)<*DEFBWI%1TXFL:?.-Q3S)2,2'L%PAF,L MX$WP([IX%E<+E*5Z*=:RH XEC/$):%R:]+A1PF:VUWJG]R6WS83?$<5) M@RA3N\C]W4-2YSK1 MJT8B^IR6H= N%Q;CO>095/8?W?"P*Z-+0^\= MM$JS&MKK.!8&6WU\U'(GVENO+"0!U@.K(GKNW&I>.0M"41^%;V(-F\^9O+7AD^3?* MV/SBT*RCD_6@#-"OKHTLBUF$RJ!_=JA7*F7X*2/SQ;7N6)F9IVYENF2-:Z6> MJT/DDB7>1&B\(]O>V,;^/ _E&_2:W?^FU(+MC7 :0JKOB-L_H:-DYW)EMH]2 M'1O7Y_PG72S,#Z1$QN5\DY]BM:3^V1;2X3PS#N[$NV'\I2Q8[VUV^=4="L@D MQA5)7(9;MWJQ1F7O*"UG5>0,>K8Q=[ 5PYZHNX)Z1/*U/( U;T'[767CH,DMU6= MFX(K\;#B.71N(J^$N,(GTUX*2CX,+V+#>18-S%2?:D*D?1ARIR&2DU.3$;:8 M),C[E(>11F(B\(*-F2#_W"/97.!Q&HD?A;RA,.FBE7;R*%L3K1B)M#4G*)P_ MN2-6 ^=/ONYBXI,_UZ^OV1>Y$+[5-BQXT0K7_ &E?CS)]#I]61>Y]5^R/>-/ M/@T7%L'%,Z(!9MEU8&G5X0UMM=-KR'8R,!;?H%O*;:OV@51IO7_P7A(Z1CA) M:9:$?_$\QXN,O*LX-U=; E;:KM7SW5K7SD)7;D2F_KV*;[Q@LM(QVYK4$L 5 M+?4/M@WN<14G%,<,!UMW2S0,GK2]7D/8ZF+_JAVK<<;>@F8Q_:9!92PL+(JM M.](K.PQPEWLP4S.T4:L64BM"]!#L;4O%!M+Z$EB">20?MB,Y=]PV:8ZK4&VU MP5Z#N--+[I!PTO$Y<;DG.O6C!T1G!M#5E:1_L)0/&"V&7Q=+B*E#BSM!REZI/J5UM:N@_Z-)$R^Z>-1Y3E* MS9WQ!VE:KJ9IM>X$>[NY77;<.V\K8 MPMF6CZR%@YAL'E*ED1FX'YUK[WPF)[OG'L[R%@YEZD$/-9XQT]X)3[WLT.;R M8UH\0ZK;Z=EM!^5;/'GJK0"K$T%6A]L=$M=>UJTZFL#1ZJ;>JF/L#F6S&=-4 MQ]L=3F<@0J^RBVGQC?@AFN.?_#]02P$"% ,4 " #K>Z]."52'O*-( !Q M] , $0 @ $ ;6-C>"TR,#$Y,#,S,2YX;6Q02P$"% ,4 M " #K>Z].1ZD-P>H( [70 $0 @ '22 ;6-C>"TR M,#$Y,#,S,2YXZ]..;H/),\& #C3@ %0 M @ 'K40 ;6-C>"TR,#$Y,#,S,5]C86PN>&UL4$L! A0#% @ MZWNO3KR4EM&J&0 IC@" !4 ( ![5@ &UC8W@M,C Q.3 S M,S%?9&5F+GAM;%!+ 0(4 Q0 ( .M[KT[H35'/*"4 !H4 @ 5 M " Z].F+-W]H\; ![@ ( %0 @ $EF ;6-C>"TR,#$Y,#,S ?,5]P&UL4$L%!@ & 8 B@$ .>S $! end